Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCS Bio Sein: CSF Biomarkers in Leptomeningeal Metastases of Breast Cancer
NCT03252912Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jan 2017
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Institut du Cancer de Montpellier. Primary endpoint: Sensitivity of the CellSearch technique on CSF samples at 2 years. Started Jan 2017; status: completed.
Beyond the preview
Go deeper on NCT03252912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03252912.